子痫前期的遗传易感性由FLT1基因附近的胎儿DNA变异决定,该基因参与血管生成调节
子痫前期遗传力估计约55%,传统基因发现方法多未成功或不可重复。该基因编码可溶性Fms样酪氨酸激酶1,通过抑制促血管生成因子信号发挥抗血管生成活性。
要点
- 子痫前期遗传力估计约55%,母体与胎儿遗传背景均影响风险。
- 全基因组关联研究在13号染色体FLT1基因附近发现胎儿基因组关联信号。
- 可溶性FLT1过量入母血可致高血压和蛋白尿等子痫前期特征。
核心结论
- 胎儿基因组中Fms样酪氨酸激酶1位点失调可能是子痫前期的基本分子缺陷。
- 该胎儿子痫前期全基因组关联研究是子痫前期生物学的重要进展。
主要发现
- 在13号染色体Fms样酪氨酸激酶1基因附近识别出单一关联信号。
- Fms样酪氨酸激酶1编码可溶性Fms样酪氨酸激酶1,后者抑制促血管生成因子信号。
- 母体血浆可溶性Fms样酪氨酸激酶1过量可致高血压和蛋白尿等子痫前期特征。
关键数值与推荐
- 子痫前期遗传力估计约55%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia risk is influenced by both the mother's genetic background and the genetics of her fetus; however, the specific genes responsible for conferring preeclampsia risk have largely remained elusive. Evidence that preeclampsia has a genetic predisposition was first detailed in the early 1960s, and overall preeclampsia heritability is estimated at ∼55%. Many traditional gene discovery approaches have been used to investigate the specific genes that contribute to preeclampsia risk, but these have largely not been successful or reproducible. Over the past decade, genome-wide association studies have allowed for significant advances in the understanding of the genetic basis of many common diseases. Genome-wide association studies are predicated on the idea that the genetic basis of many common diseases are complex and polygenic with many variants, each with modest effects that contribute to disease risk. Using this approach in preeclampsia, a large genome-wide association study recently identified and replicated the first robust fetal genomic region associated with excess risk. A screen of >7 million genetic variants in 2658 offspring from preeclamptic women and 308,292 population controls identified a single association signal close to the Fms-like tyrosine kinase 1 gene, on chromosome 13. Fms-like tyrosine kinase 1 encodes soluble Fms-like tyrosine kinase 1, a splice variant of the vascular endothelial growth factor receptor that exerts antiangiogenic activity by inhibiting signaling of proangiogenic factors. The Fms-like tyrosine kinase 1 pathway is central in preeclampsia pathogenesis because excess circulating soluble Fms-like tyrosine kinase 1 in the maternal plasma leads to the hallmark clinical features of preeclampsia, including hypertension and proteinuria. The success of this landmark fetal preeclampsia genome-wide association study suggests that well-powered, larger maternal and fetal genome-wide association study will be fruitful in identifying additional common variants that implicate causal preeclampsia genes and pathways. Such efforts will rely on the continued development of large preeclampsia consortia focused on preeclampsia genetics to obtain adequate sample sizes, detailed clinical phenotyping, and matched maternal-fetal samples. In summary, the fetal preeclampsia genome-wide association study represents an exciting advance in preeclampsia biology, suggesting that dysregulation at the Fms-like tyrosine kinase 1 locus in the fetal genome (likely in the placenta) is a fundamental molecular defect in preeclampsia.
引用
- Gray KJ, Saxena R, Karumanchi SA, et al. Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. Am J Obstet Gynecol. 2017. PMID: 29138037. doi:10.1016/j.ajog.2017.11.562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。